Results CALENDAR
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
M
T
W
T
F
S
S
Jun 2013 123456789101112131415161718192021222324252627282930
India Earnings >> Current News
You are here : Home »
Pharmaceuticals Sector
 
 Current News
12345678910Next
'Adulteration' defined differently in US and India: Ranbaxy         19th-Jun-2013
Arun Sawhney, managing director and chief executive officer, Ranbaxy continues to deny any wrong doing. He says the USFDA's ban on its products is due to different definitions of what is 'adulterated' in the US and in India.
EU fines Ranbaxy, others for blocking cheaper drugs       19th-Jun-2013
EU antitrust regulators fined nine drugmakers a total of 146 million euros on Wednesday for blocking the supply of cheaper medicines on the market, with a penalty of 94 million euros imposed on Denmark's Lundbeck .
Biocon plans Rs 1,200 capex over next 3 yrs: Citi       19th-Jun-2013
The Bangalore-based biotechnology company expects its revenue will rise 15-18 percent, driven by research services and branded formulations in India.
Glenmark gets USFDA approval for sclerosis treatment drug       19th-Jun-2013
Glenmark Generics Inc, the US-based subsidiary of Glenmark Generics Ltd (GGL) has received final approval from the US Food and Drug Administration (USFDA) for Riluzole tablets in 50 mg strength, Glenmark Pharma said in a statement.
Dr Reddy's sued for 'infringing' thyroid injection patent       19th-Jun-2013
The US Drug maker requested the court to pass an order to restrain Dr Reddy's Labs from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration
Glenmark gets final US nod for sclerosis treatment drug       19th-Jun-2013
Riluzole is indicated for treating amyotrophic lateral sclerosis and according to IMS Health data had sales of USD 64 million for year ended March 2013.
Shasun Pharma shares plunge 8%       18th-Jun-2013
Shasun Pharma's shares fell 8 percent on the back of the company's operations at its Puducherry plant being affected by the strike called by the workers. The stock fell 13.14 percent to 52-week low of Rs 55.50 in intra-day trade on the BSE.
Ranbaxy slumps to near 4-year low; rupee to add to injury       18th-Jun-2013
Ranbaxy shares have plunged more than 22 percent since it pleaded guilty to felony charges in the US last month. Further the Supreme Court in India has agreed to hear a petition against the company, which has got investors worried.
DIPP to send proposal to PMO on review of pharma FDI policy       16th-Jun-2013
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Ranbaxy issue resolved, informs Apollo Pharmacy       13th-Jun-2013
A week after issuing “cautionary advisory” against drugs made by Ranbaxy Laboratories, leading pharmacy chain Apollo Pharmacy on Thursday said it has resolved the matter and will continue to sell the drug maker’s medicines from its outlets across
Setting things right, not aware of DCGI probe: Ranbaxy         12th-Jun-2013
Agreeing to past misdeeds, Ranbaxy Laboratories says that the company is taking measure to set things right but cliams to be unaware of DCGI probe.
'Ranbaxy issue a wake up call for Indian pharma firms'       9th-Jun-2013
While stating that the issue must be utilised for making regulatory environment “more robust” in India, Shaw, however, said there should not be a “knee jerk reaction” to the episode as the drug maker has taken corrective action.
SC to hear next week PIL against Ranbaxy Laboratories       7th-Jun-2013
The Supreme Court on Friday agreed to hear next week a PIL seeking cancellation of licence granted to Ranbaxy Laboratories Ltd and for initiating probe against it for allegedly manufacturing and selling adulterated medicines.
Zydus Cadila to launch Lipaglyn in other mkts in 3-5 yrs         7th-Jun-2013
Cadila's CMD Pankaj Patel says global market size for Lipaglyn type of drug is around USD 29 billion. The drug is expected to be launched in India in Q3 and in other markets in 3-5 years.
Apollo Pharmacy halts Ranbaxy drugs sales       7th-Jun-2013
Apollo'ss medical committee reviewed the matter and recommended that the pharmacy should temporarily halt sale of Ranbaxy drugs, according to a report.

Results so Far

Search

 Best Performers
 Worst Performers
 Positive Turnarounds
 Negative Turnarounds
 Latest Results
 Sector Performance
Most Visited
 Results Calendar
 Board Meetings
 Book Closures
 Dividend Calendar
 Brokerage Reports
 FII Comments
 Pre Result Estimates
 Results At A Glance
 Interview With Management
 CNBC TV18 Live Video
Results at a glance
Moser Baer's net loss widens to Rs ... May 31
UFLEX Q4 FY2012-13 consolidated net... May 31
GMR Infra returns to profit in Q4 o... May 31
more
Press Releases
Pre Result Estimates
DLF Q4 net profit may lag estimates... May 30
GMR Infra's Q4 loss may shrink on a... May 30
Mahindra & Mahindra Q4 net seen at ... May 30
more
Management Talk
FY14 sales to grow more than 20%; d... Jun 05 Watch Video
Q4 income up 48%; growth to continu... Jun 04 Watch Video
Tamil Nadu issue to continue to hit... Jun 04 Watch Video
more
FII Comments
more
Analyst View
Suzlon hits new low after big quart... May 31
Nomura maintains buy rating on IOC,... May 31
Tata Motors: What analysts make of ... May 30
more
CNBC TV18 View
more
Brokerage Reports
Buy Gateway Distriparks; target Rs ... Jun 19
Buy LIC Housing Finance; target Rs ... Jun 19
Buy Gateway Distriparks; target Rs ... Jun 19
more
Press Conferences
Tata Motors beats street in Q4; dom... May 29 Watch Video
Dip in Q4 net fails to dent L&T's m... May 22 Watch Video
Excise duty, higher input costs hur... May 21 Watch Video
more
Analyst Concalls
more
Source : Dion Global Solutions Limited
Site Map  |  About us  |  Contact us  |  Advertise  |  Feedback  |  Disclaimer  |  Privacy Policy  |  Terms of Use
copyright © 2008. IndiaEarnings.com
Results
Results Till Now
Press Releases
Estimates
CEO CALL
Mgmt Interviews
Press Conference
Conference Calls
 
ANALYSIS
CNBC-TV18 View
Brokerage Calls
Analyst Views
NEWS